. 2021 Jul;60(4):475–483. doi: 10.30802/AALAS-JAALAS-20-000103

Table 4.

Posterior means of FEC (given as EPG) for each group across all posttreatment sampling time points and associated lower and upper bounds of the 95% CI (LCB and UCB, respectively)

Group	No. of animals	Mean	LCB	UCB	P ^b
Fenbendazole	16	10	21	39^a	0.00008^a
Ivermectin	16	28	6	83^a	0.00006^a
Fenbendazole+ivermectin	15	5	0	25^a	0.0017^a
Control	18	262	158	427	—

^{^a}

Value for the treatment group is significantly different than that for the control group.

^{^b}

P values are the probability that each treatment did not reduce FEC according to the posterior distribution of each treatment effect.